Symbol:
Ogn
Name:
osteoglycin
Description:
Involved in negative regulation of smooth muscle cell proliferation. Orthologous to human OGN (osteoglycin); INTERACTS WITH (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; 17alpha-ethynylestradiol; 2,6-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
LOC291015; mimecan
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
OGN (osteoglycin) HGNC
EggNOG, Ensembl, HomoloGene, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Ogn (osteoglycin) HGNC
Treefam, EggNOG, OrthoMCL, NCBI, OMA, HomoloGene, Panther, PhylomeDB, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Ogn (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
OGN (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
OGN (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ogn (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
OGN (osteoglycin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
OGN (osteoglycin)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Mus musculus (house mouse):
Ogn (osteoglycin)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Danio rerio (zebrafish):
ogna
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Danio rerio (zebrafish):
ognb
Alliance
DIOPT (Ensembl Compara, Hieranoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 17 14,607,442 - 14,628,274 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 17 15,447,716 - 15,467,359 (-) Ensembl Rnor_6.0 Ensembl 17 14,607,442 - 14,627,937 (-) Ensembl Rnor_5.0 17 17,506,166 - 17,527,131 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 17 20,987,029 - 21,007,525 (-) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 17 20,987,030 - 21,007,504 (-) NCBI Celera 17 14,763,600 - 14,783,780 (-) NCBI Celera Cytogenetic Map 17 p14 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
(2,4,5-trichlorophenoxy)acetic acid decreases expression ISO RGD:1317794 6480464 2 more ... CTD PMID:18579281 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of OGN mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE increases expression EXP 6480464 Topotecan results in increased expression of OGN mRNA CTD PMID:25729387 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of OGN mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO RGD:1317794 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1317794 6480464 Ethinyl Estradiol results in increased expression of OGN mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1317794 6480464 Estradiol results in increased expression of OGN mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1317793 6480464 Estradiol results in increased expression of OGN mRNA CTD PMID:25878060 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317794 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317793 6480464 Tetrachlorodibenzodioxin affects the expression of OGN mRNA CTD PMID:30203000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317794 6480464 Tetrachlorodibenzodioxin results in increased expression of OGN mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317794 6480464 Tetrachlorodibenzodioxin affects the expression of OGN mRNA CTD PMID:21570461 2,4-diaminotoluene decreases expression ISO RGD:1317794 6480464 2, 4-diaminotoluene results in decreased expression of OGN mRNA CTD PMID:20713471 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of OGN mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1317793 6480464 Lactic Acid results in increased expression of OGN mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1317794 6480464 tetrabromobisphenol A results in decreased expression of OGN mRNA CTD PMID:25172293 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1317794 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1317793 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1317794 6480464 Methylcholanthrene results in decreased expression of OGN mRNA CTD PMID:20713471 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of OGN mRNA CTD PMID:24780913 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:19480007 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of OGN mRNA CTD PMID:28959563 aldrin decreases expression ISO RGD:1317794 6480464 Aldrin results in decreased expression of OGN mRNA CTD PMID:18579281 antirheumatic drug increases expression ISO RGD:1317793 6480464 Antirheumatic Agents results in increased expression of OGN mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of OGN mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO RGD:1317794 6480464 Benzo(a)pyrene results in decreased expression of OGN mRNA CTD PMID:15034205 benzo[a]pyrene increases expression ISO RGD:1317794 6480464 Benzo(a)pyrene results in increased expression of OGN mRNA CTD PMID:22228805 bisphenol A decreases expression ISO RGD:1317794 6480464 bisphenol A results in decreased expression of OGN mRNA CTD PMID:20739668 bisphenol A multiple interactions ISO RGD:1317793 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of OGN mRNA CTD PMID:25181051 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of OGN mRNA CTD PMID:25993096 carbon nanotube decreases expression ISO RGD:1317794 6480464 Nanotubes, Carbon analog results in decreased expression of OGN mRNA, Nanotubes, Carbon results in decreased expression of OGN mRNA CTD PMID:25554681 cisplatin multiple interactions ISO RGD:1317793 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of OGN mRNA CTD PMID:20705681 copper(II) sulfate decreases expression ISO RGD:1317794 6480464 Copper Sulfate results in decreased expression of OGN mRNA CTD PMID:18579281 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of OGN mRNA CTD PMID:18480146 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of OGN mRNA CTD PMID:23914054 dexamethasone multiple interactions ISO RGD:1317794 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:1317793 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 diazinon increases expression EXP 6480464 Diazinon results in increased expression of OGN mRNA CTD PMID:29108742 dibutyl phthalate increases expression ISO RGD:1317794 6480464 Dibutyl Phthalate results in increased expression of OGN mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:1317794 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OGN mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of OGN mRNA CTD PMID:21551480 , PMID:25152437 doxorubicin decreases expression ISO RGD:1317793 6480464 Doxorubicin results in decreased expression of OGN mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of OGN mRNA CTD PMID:29391264 furan increases expression EXP 6480464 furan results in increased expression of OGN mRNA CTD PMID:27387713 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of OGN mRNA CTD PMID:24915197 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of OGN mRNA CTD PMID:26302742 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of OGN mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1317793 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 methotrexate decreases expression ISO RGD:1317793 6480464 Methotrexate results in decreased expression of OGN mRNA CTD PMID:17400583 N-nitrosodiethylamine increases expression ISO RGD:1317794 6480464 Diethylnitrosamine results in increased expression of OGN mRNA CTD PMID:24535843 nickel atom decreases expression ISO RGD:1317793 6480464 Nickel results in decreased expression of OGN mRNA CTD PMID:25583101 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of OGN mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of OGN mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of OGN mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1317794 6480464 Ozone results in decreased expression of OGN mRNA CTD PMID:12763052 paclitaxel multiple interactions ISO RGD:1317793 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of OGN mRNA CTD PMID:20705681 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of OGN mRNA CTD PMID:18158353 potassium dichromate increases expression ISO RGD:1317794 6480464 Potassium Dichromate results in increased expression of OGN mRNA CTD PMID:23608068 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 rac-lactic acid increases expression ISO RGD:1317793 6480464 Lactic Acid results in increased expression of OGN mRNA CTD PMID:30851411 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of OGN mRNA CTD PMID:27900601 serpentine asbestos decreases expression ISO RGD:1317794 6480464 Asbestos, Serpentine results in decreased expression of OGN mRNA CTD PMID:16251409 silver atom decreases expression ISO RGD:1317794 6480464 Silver results in decreased expression of OGN mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1317794 6480464 Silver results in decreased expression of OGN mRNA CTD PMID:27131904 silver(1+) decreases expression ISO RGD:1317794 6480464 Silver results in decreased expression of OGN mRNA CTD PMID:27131904 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of OGN mRNA CTD PMID:21865292 sodium arsenite increases expression ISO RGD:1317793 6480464 sodium arsenite results in increased expression of OGN mRNA CTD PMID:17879257 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of OGN mRNA, sodium arsenite results in decreased expression of OGN protein CTD PMID:19072884 , PMID:29459688 sodium arsenite increases expression ISO RGD:1317794 6480464 sodium arsenite results in increased expression of OGN mRNA CTD PMID:18812580 sodium fluoride decreases expression ISO RGD:1317794 6480464 Sodium Fluoride results in decreased expression of OGN mRNA CTD PMID:27862939 sulforaphane decreases expression ISO RGD:1317794 6480464 sulforafan results in decreased expression of OGN mRNA CTD PMID:30529165 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of OGN mRNA CTD PMID:21865292 tacrolimus hydrate increases expression ISO RGD:1317794 6480464 Tacrolimus results in increased expression of OGN mRNA CTD PMID:29362864 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of OGN mRNA CTD PMID:16239168 tetrachloromethane affects expression ISO RGD:1317794 6480464 Carbon Tetrachloride affects the expression of OGN mRNA CTD PMID:17484886 titanium dioxide decreases expression ISO RGD:1317794 6480464 titanium dioxide results in decreased expression of OGN mRNA CTD PMID:23557971 , PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of OGN mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of OGN mRNA CTD PMID:25729387 triclosan increases expression ISO RGD:1317793 6480464 Triclosan results in increased expression of OGN mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1317794 6480464 trimellitic anhydride results in decreased expression of OGN mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:1317794 6480464 troglitazone results in increased expression of OGN mRNA CTD PMID:28973697 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of OGN mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:1317794 6480464 Valproic Acid results in increased expression of OGN mRNA CTD PMID:24896083 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of OGN mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of OGN mRNA CTD PMID:20566332 
Gene-Chemical Interaction Annotations
